The plasma concentration of N-terminal proatrial natriuretic factor anf (1-98) is related to prognosis in severe heart failure
- 1 April 1994
- journal article
- clinical trial
- Published by Wiley in Clinical Cardiology
- Vol. 17 (4), 191-195
- https://doi.org/10.1002/clc.4960170409
Abstract
Due to its longer halflife, the N-terminal of ANF prohormone, ANF(1-98), has plasma concentrations that exceed those of ANF itself by a factor of 10 or more. It is also less prone to rapid changes secondary to hemodynamic alterations. To evaluate the prognostic significance of ANF(1-98) plasma levels in severe heart failure (NYHA IV), the peptide was measured by radioimmunoassay in plasma samples from patients randomized to additional treatment with enalapril (n = 78) or placebo (n = 61) (CONSENSUS study). In the placebo group there was a positive relation between mortality after 6 months and baseline ANF(1-98) level. Because of a reduced mortality, especially among patients with high ANF(1-98) levels, there was no such relation in the patients treated with enalapril. For both groups there was a positive relationship between increase in ANF(1-98) after 6 weeks of treatment and mortality, while a decrease signaled a favorable prognosis. It is concluded that the magnitude and changes of plasma ANF(1-98) provide information on prognosis and therapeutic effects with respect to mortality in patients with severe heart failure. Plasma ANF(1-98) may serve as a useful clinical biochemical parameter in the treatment of heart failure.Keywords
This publication has 22 references indexed in Scilit:
- Rate-induced increase in plasma atrial natriuretic factor can occur independently of changes in atrial wall stretchAmerican Journal of Physiology-Heart and Circulatory Physiology, 1991
- Release of ANF, proANF 1-98, and proANF 31-67 from isolated rat atria by atrial distensionAmerican Journal of Physiology-Heart and Circulatory Physiology, 1991
- Release of atrial natriuretic factor during selective cardiac alpha- and beta-adrenergic stimulation, intracoronary Ca2+ infusion, and aortic constriction in pigs.Circulation Research, 1991
- γ-Atrial Natriuretic Polypeptide (γANP)-Derived Peptides in Human Plasma: Cosecretion of N-TerminalγANP Fragment andαANP*Journal of Clinical Endocrinology & Metabolism, 1988
- Identification and Plasma Concentrations of the N-Terminal Fragment of Proatrial Natriuretic Factor in Man*Journal of Clinical Endocrinology & Metabolism, 1988
- NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: Identification, radioimmunoassay and half-lifePeptides, 1988
- The propeptide Asn1–Tyr126 is the storage form of rat atrial natriuretic factorBiochemical Journal, 1987
- Molecular forms of atrial natriuretic polypeptides in mammalian tissues and plasmaBiochemical and Biophysical Research Communications, 1985
- The amino acid sequence of an atrial peptide with potent diuretic and natriuretic propertiesBiochemical and Biophysical Research Communications, 1983
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981